DK1448207T3 - Doseringsplan og farmaceutisk sammensætning af nödprævention - Google Patents

Doseringsplan og farmaceutisk sammensætning af nödprævention

Info

Publication number: DK1448207T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; dosage schedule; emergency contraception; contraception; emergency
Prior art date: 2001-11-27

Application number

DK02783334T

Other languages

Danish (da)

English (en)

Inventor

Look Paul F A Van

Illesne Balogh

Katalin Komandi

Laszlo Nemes

Zsolt Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2002-11-26

Publication date

2005-06-27

2002-11-26 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2005-06-27 Application granted granted Critical

2005-06-27 Publication of DK1448207T3 publication Critical patent/DK1448207T3/da

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

DK02783334T 2001-11-27 2002-11-26 Doseringsplan og farmaceutisk sammensætning af nödprævention DK1448207T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
EP02783334A EP1448207B1 (fr)	2001-11-27	2002-11-26	Posologie et composition pharmaceutique pour contraception d'urgence
PCT/HU2002/000129 WO2003045397A1 (fr)	2001-11-27	2002-11-26	Posologie et composition pharmaceutique pour contraception d'urgence

Publications (1)

Publication Number	Publication Date
DK1448207T3 true DK1448207T3 (da)	2005-06-27

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02783334T DK1448207T3 (da)	2001-11-27	2002-11-26	Doseringsplan og farmaceutisk sammensætning af nödprævention

Country Status (33)

Country	Link
US (1)	US20050288264A2 (fr)
EP (1)	EP1448207B1 (fr)
JP (1)	JP2005516904A (fr)
KR (1)	KR100908161B1 (fr)
CN (1)	CN1551774A (fr)
AP (1)	AP1849A (fr)
AT (1)	ATE293978T1 (fr)
AU (1)	AU2002347401A1 (fr)
BR (1)	BR0210595A (fr)
CA (1)	CA2450359C (fr)
DE (1)	DE60203929T2 (fr)
DK (1)	DK1448207T3 (fr)
EA (1)	EA006545B1 (fr)
EC (1)	ECSP045171A (fr)
ES (1)	ES2239727T3 (fr)
GE (1)	GEP20063882B (fr)
HR (1)	HRP20040584B1 (fr)
HU (1)	HU227198B1 (fr)
IL (1)	IL159394A0 (fr)
IS (1)	IS2691B (fr)
MA (1)	MA27076A1 (fr)
MX (1)	MXPA04005104A (fr)
NO (1)	NO333984B1 (fr)
NZ (1)	NZ530056A (fr)
OA (1)	OA12730A (fr)
PL (1)	PL206010B1 (fr)
PT (1)	PT1448207E (fr)
RS (1)	RS50768B (fr)
SI (1)	SI1448207T1 (fr)
TN (1)	TNSN04048A1 (fr)
UA (1)	UA79942C2 (fr)
WO (1)	WO2003045397A1 (fr)
ZA (1)	ZA200404114B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007338843B2 (en) *	2006-12-20	2013-05-09	Teva Women's Health, Inc.	Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) *	2007-12-20	2019-09-24	Teva Womenss Health Inc	"método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
CA2745541C (fr) *	2008-12-12	2016-11-08	Laboratoire Hra-Pharma	Methode de contraception
RS55331B1 (sr)	2009-04-14	2017-03-31	Hra Pharma Lab	Postupak za kontracepciju po potrebi
CN102458386B (zh)	2009-06-23	2016-04-06	拜耳知识产权有限责任公司	用于紧急避孕的药物组合物
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
HUE029252T2 (en)	2011-06-01	2017-02-28	Estetra Sprl	Process for the preparation of intermediates of estetrol
SG195121A1 (en)	2011-06-01	2013-12-30	Estetra S A	Process for the production of estetrol intermediates
EP2383279A1 (fr)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Procédé de préparation d'estetrol
HRP20170797T1 (hr) *	2011-08-11	2017-08-11	Estetra S.P.R.L.	Primjena estetrola kao hitnog kontraceptiva
US9579330B2 (en)	2012-11-22	2017-02-28	Bayer Pharma Aktiengesellschaft	Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
US9655887B2 (en)	2013-05-23	2017-05-23	Bayer Pharma Aktiengesellschaft	Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
RS61777B1 (sr)	2015-06-18	2021-06-30	Estetra Sprl	Oralno-disperzibilna tableta koja sadrži estetrol
CN116077454A (zh)	2015-06-18	2023-05-09	埃斯特拉有限责任公司	含雌四醇组分的口腔分散剂量单位
HUE054589T2 (hu)	2015-06-18	2021-09-28	Estetra Sprl	Szájban diszpergálódó esztetrol tartalmú tabletta
MD3310333T2 (ro)	2015-06-18	2020-06-30	Estetra Sprl	Unitate de dozare orodispersabilă care conține un component estetrol
CA3178291A1 (fr)	2016-08-05	2018-04-12	Estetra Srl	Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles
DK3781171T3 (da)	2018-04-19	2022-05-02	Estetra Srl	Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
WO2022026901A2 (fr) *	2020-07-30	2022-02-03	Acer Therapeutics Inc.	Antagonistes nk pour la contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 EP EP02783334A patent/EP1448207B1/fr not_active Expired - Lifetime
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/fr not_active Ceased
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 CA CA2450359A patent/CA2450359C/fr not_active Expired - Lifetime
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
GEP20063882B (en)	2006-07-25
CN1551774A (zh)	2004-12-01
EA006545B1 (ru)	2006-02-24
HUP0105173A2 (hu)	2003-08-28
EP1448207B1 (fr)	2005-04-27
RS4204A (sr)	2007-02-05
IL159394A0 (en)	2004-06-01
IS7065A (is)	2003-12-05
IS2691B (is)	2010-10-15
HUP0105173A3 (en)	2004-03-29
DE60203929T2 (de)	2006-01-19
HRP20040584A2 (en)	2005-02-28
SI1448207T1 (en)	2005-10-31
EP1448207A1 (fr)	2004-08-25
NO20041607L (no)	2004-04-20
KR100908161B1 (ko)	2009-07-16
OA12730A (fr)	2006-06-28
ECSP045171A (es)	2004-08-27
TNSN04048A1 (en)	2006-06-01
JP2005516904A (ja)	2005-06-09
ES2239727T3 (es)	2005-10-01
UA79942C2 (en)	2007-08-10
US20050032755A1 (en)	2005-02-10
EA200400731A1 (ru)	2004-12-30
NZ530056A (en)	2005-02-25
MXPA04005104A (es)	2004-08-19
CA2450359A1 (fr)	2003-06-05
AU2002347401A1 (en)	2003-06-10
BR0210595A (pt)	2004-06-08
RS50768B (sr)	2010-08-31
PT1448207E (pt)	2005-08-31
WO2003045397A1 (fr)	2003-06-05
ZA200404114B (en)	2005-10-26
HUP0105173D0 (en)	2002-02-28
PL206010B1 (pl)	2010-06-30
KR20040066088A (ko)	2004-07-23
DE60203929D1 (de)	2005-06-02
AP2004003046A0 (en)	2004-06-30
US20050288264A2 (en)	2005-12-29
NO333984B1 (no)	2013-11-04
AP1849A (en)	2008-05-23
PL369520A1 (en)	2005-04-18
ATE293978T1 (de)	2005-05-15
CA2450359C (fr)	2011-05-10
MA27076A1 (fr)	2004-12-20
HRP20040584B1 (en)	2012-11-30
HU227198B1 (en)	2010-10-28

Publication	Publication Date	Title
DK1448207T3 (da)	2005-06-27	Doseringsplan og farmaceutisk sammensætning af nödprævention
DK1562556T3 (da)	2013-03-25	Farmaceutiske sammensætninger og doseringsformer af thalidomid
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
BRPI0209720A2 (pt)	2017-06-13	dosagem e embalagem de medicação com liberação controlada
DE60121992D1 (de)	2006-09-14	Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
DK1478339T3 (da)	2008-08-25	Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
DK1158992T3 (da)	2003-12-29	Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
FI20011478L (fi)	2003-01-06	Farmaseuttinen koostumus
PT1207867E (pt)	2006-07-31	Formas de administracao farmaceuticas orais retardadas contendo tramadol
PL368519A1 (pl)	2005-04-04	Kompozycje farmaceutyczne amlodypiny i atorwastatyny
HUP0401656A3 (en)	2012-05-02	Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
DK1537096T3 (da)	2009-02-02	Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
DK1949936T3 (da)	2011-08-15	Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
NO20033123L (no)	2003-09-03	Terapeutisk hinne dannende sammensetning og behandlingsplan derav
GB0108470D0 (en)	2001-05-23	Pharmaceutical compositions and their use
FI20022128A7 (fi)	2003-06-06	Farmaseuttinen koostumus
PL361518A1 (pl)	2004-02-09	Zastosowanie substancji oraz kompozycja farmaceutyczna
DE60329614D1 (de)	2009-11-19	Polymerzusammensetzung sowie diese enthaltende darreichungsformen
DE60232445D1 (de)	2009-07-09	Cetirizin und pseudoephedrin enthaltende tablette
HUP0401862A3 (en)	2009-03-30	Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
EE200300468A (et)	2004-02-16	Pravastatiini stabiilne farmatseutiline kompositsioon
NO20034172D0 (no)	2003-09-19	Bisykliske guanidinderivater og terapeutiske anvendelser derav
DK1385513T3 (da)	2007-01-15	Farmaceutiske kombinationer af pyridoindollonderivater og anticancermidler
DK1406591T3 (da)	2007-06-25	Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron
EP1413314A4 (fr)	2004-12-22	Composition medicinale